IRCT20240304061159N1招募中2 期
Comparing the efficacy and safety of the combination of minoxidil 2.5 mg dutasteride 0.5 mg with minoxidil 2.5 mg and dutasteride 0.5 mg alone in the treatment of androgenic alopecia in men
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •Patients aged 18 to 60 years with male androgenetic alopecia grade 2 to 4 vertex of Norwood-Hamilton classification who have not received any other medical treatment for hair loss in the last 6 months
排除标准
- •Patients who are not diagnosed with androgenic alopecia or are being treated with other drugs, and patients with grade I of androgenic alopecia and patients with severe complications after taking drugs are excluded from the study. Liver and TSH tests (tests in the last 6 months can be it is accepted) it is requested that they will be excluded from the study in case of disorder. Patients with a history of hair transplantation and patients with prostate and breast cancer in the last 5 years will be excluded from the study. patients with a history of diseases related to the right ventricle and neurogenic hypotension And spinal injuries are not included in the study.
研究者
相似试验
招募中
2 期
Evaluation of the safety and efficacy of combination of neostigmine and ketorolac added to reduced local anesthetic mixture dose through medial canthus injection in vitrectomy surgeryAnaesthesiaPACTR202204650206424Research institute of Ophthalmology50
招募中
不适用
Evaluation of efficacy and safety of combinationtherapy with trastuzumab and eribulin for HER2-positive inoperableness or metastatic breast cancerJPRN-UMIN000007113Wakayama Medical University Department of Thoracic and Cardiovascular Surgery35
已完成
4 期
Comparison of single drug (rosuvastatin 40 mg)versus two drugs (rosuvastatin 20 mg and fenofibrate 145 mg) for the management of mixed dyslipidemia in patients with coronary artery disease.CTRI/2017/01/007633INDIRA GANDHI MEDICAL COLLEGE165
已完成
4 期
Evaluation on efficacy and safety of a combination therapy of rituximab with bendamustin in the patients with relapsed or resistnat low grade B-cell non-Hodgkin lymphomapatients with relapsed or resistant low grade B-cell non-Hodgkin lymphomaJPRN-UMIN000008638Hiroshima University26
已完成
不适用
Comparison of efficacy and safety of combination of insulin glargine and lixisenatide + glulisine therapy and intensive insulin therapy in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000041551Minami Osaka Hospital20